In a recent study published in EBioMedicine, a group of researchers determined the impact of nicotinamide mononucleotide (NMN) on Clusters of differentiation 4 + (CD4 +) Thymus cells (T cells) viz. T ...

The decrease in CD4 cells during HIV infection seems to be driven by immune activation, which does not always correlate with viral load. Experienced clinicians are all too familiar with the ...

In the frustrating 40-year effort to develop a vaccine for HIV/AIDS, hardworking scientists could certainly use some help. Newly published research suggests they may have found some in the form of a ...

As a part of its life cycle, human immunodeficiency virus-1 (HIV-1) inserts a copy of its DNA into human immune cells. Some of these newly infected immune cells can then transition into a dormant, ...

A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting white blood cells, which play a crucial role in coordinating the immune ...

Living with HIV means becoming fluent in a language of numbers that might seem confusing at first but actually hold the key to your health and future. Two numbers in particular – your viral load and ...

The results of three randomized, controlled trials (SAPiT, STRIDE, and CAMELIA) demonstrate that, for coinfected patients with advanced immunosuppression, the survival benefit of starting ART within ...

There are currently ~38 million people worldwide living with HIV. If left untreated, HIV infection progresses to acquired immunodeficiency syndrome (AIDS) where patients become extremely vulnerable to ...

Scanning electron micrograph showing HIV (yellow) attacking a human T cell (blue). In a new study, Johns Hopkins Medicine-led researchers report on a person living with HIV who had a dramatic drop in ...